124 related articles for article (PubMed ID: 36272241)
1. Unraveling the peripheral and local role of inflammatory cytokines in glioblastoma survival.
Cavalheiro VJ; Campos ACP; Lima LGCA; Roça CT; Docema MFL; Lancellotti CLP; Martinez RCR; Pagano RL; Chammas R; Teixeira MJ; Maldaun MVC; Neville IS
Cytokine; 2023 Jan; 161():156059. PubMed ID: 36272241
[TBL] [Abstract][Full Text] [Related]
2. Analysis of the cancer genome atlas (TCGA) database identifies an inverse relationship between interleukin-13 receptor α1 and α2 gene expression and poor prognosis and drug resistance in subjects with glioblastoma multiforme.
Han J; Puri RK
J Neurooncol; 2018 Feb; 136(3):463-474. PubMed ID: 29168083
[TBL] [Abstract][Full Text] [Related]
3. Serum exosomes and cytokines promote a T-helper cell type 2 environment in the peripheral blood of glioblastoma patients.
Harshyne LA; Nasca BJ; Kenyon LC; Andrews DW; Hooper DC
Neuro Oncol; 2016 Feb; 18(2):206-15. PubMed ID: 26180083
[TBL] [Abstract][Full Text] [Related]
4. Immune cell infiltrate differences in pilocytic astrocytoma and glioblastoma: evidence of distinct immunological microenvironments that reflect tumor biology.
Yang I; Han SJ; Sughrue ME; Tihan T; Parsa AT
J Neurosurg; 2011 Sep; 115(3):505-11. PubMed ID: 21663411
[TBL] [Abstract][Full Text] [Related]
5. The influence of maximum safe resection of glioblastoma on survival in 1229 patients: Can we do better than gross-total resection?
Li YM; Suki D; Hess K; Sawaya R
J Neurosurg; 2016 Apr; 124(4):977-88. PubMed ID: 26495941
[TBL] [Abstract][Full Text] [Related]
6. Residual tumor volume versus extent of resection: predictors of survival after surgery for glioblastoma.
Grabowski MM; Recinos PF; Nowacki AS; Schroeder JL; Angelov L; Barnett GH; Vogelbaum MA
J Neurosurg; 2014 Nov; 121(5):1115-23. PubMed ID: 25192475
[TBL] [Abstract][Full Text] [Related]
7. Nuclear FABP7 immunoreactivity is preferentially expressed in infiltrative glioma and is associated with poor prognosis in EGFR-overexpressing glioblastoma.
Liang Y; Bollen AW; Aldape KD; Gupta N
BMC Cancer; 2006 Apr; 6():97. PubMed ID: 16623952
[TBL] [Abstract][Full Text] [Related]
8. Cytokine Networks and Survivin Peptide-Specific Cellular Immune Responses Predict Improved Survival in Patients With Glioblastoma Multiforme.
Zhenjiang L; Rao M; Luo X; Valentini D; von Landenberg A; Meng Q; Sinclair G; Hoffmann N; Karbach J; Altmannsberger HM; Jäger E; Peredo IH; Dodoo E; Maeurer M
EBioMedicine; 2018 Jul; 33():49-56. PubMed ID: 30049387
[TBL] [Abstract][Full Text] [Related]
9. Immuno markers in newly diagnosed glioblastoma patients underwent Stupp protocol after neurosurgery: a retrospective series.
Gurrieri L; Mercatali L; Ibrahim T; Fausti V; Dall'Agata M; Riva N; Ranallo N; Pasini G; Tazzari M; Foca F; Bartolini D; Riccioni L; Cavatorta C; Morigi FP; Bulgarelli J; Cocchi C; Ghini V; Tosatto L; Martinelli G; Pession A; Ridolfi L
J Neurooncol; 2023 Aug; 164(1):55-64. PubMed ID: 37584750
[TBL] [Abstract][Full Text] [Related]
10. Systematic histopathological analysis of different 5-aminolevulinic acid-induced fluorescence levels in newly diagnosed glioblastomas.
Kiesel B; Mischkulnig M; Woehrer A; Martinez-Moreno M; Millesi M; Mallouhi A; Czech T; Preusser M; Hainfellner JA; Wolfsberger S; Knosp E; Widhalm G
J Neurosurg; 2018 Aug; 129(2):341-353. PubMed ID: 29076783
[TBL] [Abstract][Full Text] [Related]
11. New insights for precision treatment of glioblastoma from analysis of single-cell lncRNA expression.
Meng Q; Zhang Y; Li G; Li Y; Xie H; Chen X
J Cancer Res Clin Oncol; 2021 Jul; 147(7):1881-1895. PubMed ID: 33693962
[TBL] [Abstract][Full Text] [Related]
12. Glioblastoma in the elderly: the effect of aggressive and modern therapies on survival.
Babu R; Komisarow JM; Agarwal VJ; Rahimpour S; Iyer A; Britt D; Karikari IO; Grossi PM; Thomas S; Friedman AH; Adamson C
J Neurosurg; 2016 Apr; 124(4):998-1007. PubMed ID: 26452121
[TBL] [Abstract][Full Text] [Related]
13. Molecular Crosstalk between T Cells and Tumor Uncovers GBM-Specific T Cell Signatures in Blood: Noninvasive GBM Diagnosis Using Immunosensors.
Dhinakaran AK; Dharmalingam P; Ganesh S; Venkatakrishnan K; Das S; Tan B
ACS Nano; 2022 Sep; 16(9):14134-14148. PubMed ID: 36040842
[TBL] [Abstract][Full Text] [Related]
14. The predominant expression of cancer stem cell marker ALDH1A3 in tumor infiltrative area is associated with shorter overall survival of human glioblastoma.
Gan C; Pierscianek D; El Hindy N; Ahmadipour Y; Keyvani K; Sure U; Zhu Y
BMC Cancer; 2020 Jul; 20(1):672. PubMed ID: 32680476
[TBL] [Abstract][Full Text] [Related]
15. Cerebrospinal fluid cytokine levels are associated with macrophage infiltration into tumor tissues of glioma patients.
Kemmerer CL; Schittenhelm J; Dubois E; Neumann L; Häsler LM; Lambert M; Renovanz M; Kaeser SA; Tabatabai G; Ziemann U; Naumann U; Kowarik MC
BMC Cancer; 2021 Oct; 21(1):1108. PubMed ID: 34654395
[TBL] [Abstract][Full Text] [Related]
16. Targeting glioblastoma with NK cells and mAb against NG2/CSPG4 prolongs animal survival.
Poli A; Wang J; Domingues O; Planagumà J; Yan T; Rygh CB; Skaftnesmo KO; Thorsen F; McCormack E; Hentges F; Pedersen PH; Zimmer J; Enger PØ; Chekenya M
Oncotarget; 2013 Sep; 4(9):1527-46. PubMed ID: 24127551
[TBL] [Abstract][Full Text] [Related]
17. Immune tumoral microenvironment in gliomas: focus on CD3
Belghali MY; Admou B; Brahimi M; Khouchani M; Ba-M'hamed S
Immunol Res; 2022 Apr; 70(2):224-239. PubMed ID: 35006549
[TBL] [Abstract][Full Text] [Related]
18. Local Targeting of NAD
Li M; Kirtane AR; Kiyokawa J; Nagashima H; Lopes A; Tirmizi ZA; Lee CK; Traverso G; Cahill DP; Wakimoto H
Cancer Res; 2020 Nov; 80(22):5024-5034. PubMed ID: 32998997
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of tumor-derived MRI-texture features for discrimination of molecular subtypes and prediction of 12-month survival status in glioblastoma.
Yang D; Rao G; Martinez J; Veeraraghavan A; Rao A
Med Phys; 2015 Nov; 42(11):6725-35. PubMed ID: 26520762
[TBL] [Abstract][Full Text] [Related]
20. Single-Cell Atlas Reveals Complexity of the Immunosuppressive Microenvironment of Initial and Recurrent Glioblastoma.
Fu W; Wang W; Li H; Jiao Y; Huo R; Yan Z; Wang J; Wang S; Wang J; Chen D; Cao Y; Zhao J
Front Immunol; 2020; 11():835. PubMed ID: 32457755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]